Cynvenio’s LiquidBiopsy platform sold to USC and the Mayo Clinic

Cynvenio Biosystems’ innovative LiquidBiopsy® technology is being used at USC and the Mayo Clinic to find mutating tumor cells in the blood and help doctors diagnose and treat cancer without the need for a surgical biopsy. The company began shipping the system earlier this year and ultimately wants to put one in every cancer clinic.
“This is the first complete system, from blood draw to DNA sequencing,” said Chief Executive André de Fusco. “If we find a number of cancer cells that are not heavily mutated, fine. But if they are mutated, those cells can be targeted by drugs from the big pharma companies.”
Read the full article:
Cutting Edge Without The Knife